Worldwide, dementia is considered the seventh leading cause of death and has been classified as a global public health priority by the World Health Organization (WHO) [1]. The outlook for the future appears particularly alarming due to demographic change. In Germany alone, 2.8 million people are projected to be living with dementia by 2050, representing a 65% increase compared to 2019 [2]. Dementia presents in many forms, with Alzheimer's disease being the most common, accounting for 60–70% of all cases [1]. The disease has a significant impact on daily life—not only for those affected but also for family members and caregivers [3,4]. Although treatments exist to alleviate symptoms, there is currently no cure [5]. Due to the immense social impact of the disease, continued research into potential therapeutic approaches is essential. Alzheimer's disease is triggered by a combination of lifestyle and environmental factors, as well as genetic predisposition [6]. While the disease can be inherited, the associated genes also serve as potential targets for therapeutic intervention [7, 8]. We are investigating Alzheimer’s disease in relation to the 'Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells' (NF-κB). The activation of this transcription factor is crucial for neuronal protection; however, in many affected individuals, TNFα-mediated NF-κB activation is impaired due to germline mutations. The genetic context may also aid in the earlier identification of Alzheimer’s disease, allowing for timely initiation of therapeutic strategies.
[1] World Health Organization: Dementia. Online verfügbar unter https://www.who.int/news-room/fact-sheets/detail/dementia#:~:text=Worldwide%2C%20around%2055%20million%20people,and%20139%20million%20in%202050., zuletzt geprüft am 26.10.2022.
[2] Nichols et al.: Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. The Lancet Public Health. 2022.
[3] Lane et al.: Alzheimer's disease. European journal of neurology. 2018.
[4] Athanasiadou et al.: Care of Patients with Alzheimer's Disease. Advances in experimental medicine and biology. 2021
[5] Breijyeh and Karaman: Comprehensive Review on Alzheimer's Disease: Causes and Treatment. Molecules. 2020.
[6] Sun et al.: The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer's Disease. International journal of molecular sciences. 2022.
[7] Bellenguez et al.: New insights into the genetic etiology of Alzheimer's disease and related dementias. Nature genetics. 2022
[8] Gatz et al.: Role of genes and environments for explaining Alzheimer disease. Archives of general psychiatry. 2006
[9] Kaltschmidt et al.: NF-κB in Alzheimer’s Disease: Friend or Foe? Opposite Functions in Neurons and Glial Cells. Int. J. Mol. Sci. 2024.